This inventor holds 1 USPTO granted patent. Top assignee: Creighton University. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Imre Mezom: Innovator in Antitumor Peptides
Introduction
Imre Mezom is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptides with antitumor effects. His work is characterized by a focus on innovative solutions to combat cancer.
Latest Patents
Imre Mezom holds a patent for "GnRH analogues with antitumour effects and pharmaceutical compositions thereof." This invention provides peptides and pharmacologically active compounds, including gonadotropin-releasing hormone (GnRH) analogues, which demonstrate antitumor effects. The patent outlines the formulas of these compounds and includes compositions that incorporate these peptides and compounds.
Career Highlights
Imre Mezom is affiliated with Creighton University, where he continues to advance his research in the pharmaceutical sciences. His work has garnered attention for its potential impact on cancer treatment, showcasing his dedication to improving patient outcomes through innovative therapies.
Collaborations
Throughout his career, Imre has collaborated with esteemed colleagues, including Richard F. Murphy and Melinda Mora. These partnerships have enriched his research and contributed to the development of effective pharmaceutical solutions.
Conclusion
Imre Mezom's contributions to the field of antitumor peptides highlight his role as an innovative inventor. His patent on GnRH analogues represents a significant advancement in cancer treatment, underscoring the importance of research and collaboration in the pursuit of medical breakthroughs.